Dr. Ackermann serves as the co-founder and COO for Arrivo Management LLC. He is the founder of Magnatas, LLC, supporting healthcare companies and venture firms in strategy development, business planning, organizational effectiveness, and process improvement. Previously, he served as Senior VP for Global Commercial Solutions at Quintiles (IQVIA) leading the integration of clinical and commercial activities. Prior to Quintiles, Michael spent more than 18 years at Eli Lilly and Company where he served as the leader of the US Neuroscience Business Unit. He grew revenue to over $4B and led the unit's performance improvement, including the turnaround of major product, and overseeing two successful product launches. Michael holds a BS from Hampden-Sydney College in VA, a PhD in immunology from the Drexel University College of Medicine, and an MBA from Kenan-Flagler School of Business at UNC Chapel Hill.